TWiV 901: COVID-19 clinical update #115 with Dr. Daniel Griffin
In COVID-19 clinical update #115, Dr. Griffin reviews cross-variant immunity without vaccination, EUA for boosters in 5-11 year olds, B.1.1.529 attack rate, scent dogs, Omicron and pets, Paxlovid, Veklury, Fluvoxamine, antigen positivity after isolation, inflammasome activation and severe disease, and GI persistence and fecal shedding. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Limited cross-variant immunity without vaccination (Nature) EUA for boosters in 5-11 year olds (FDA) Stages of COVID-19 (AIDS Rev) B.1.1.529 attack rate in Australia (JID) Sce...
Source: This Week in Virology - MP3 Edition - May 21, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Kidney Transplant Medications: Using ramipril to control protein in urine
Don Holzheimer received a kidney transplant from his brother. Afterwards, he volunteered to participate in a clinical trial extending the use of a medication (ramipril) that has been used to control blood pressure to also control levels of protein in urine. This clinical trial also replaces calcineurin inhibitors (cyclosporine or Prograf) with sirolimus (Rapamune) to balance the effect of immunosuppressant medications. He has responded well to the medication and his doctor will be prescribing the use of this experimental mediation to continue. He reviews the experience of participating and the benefits of participating i...
Source: MUSC Organ Transplantation Surgery Podcast - April 5, 2014 Category: Transplant Surgery Authors: Medical Univeristy of South Carolina Source Type: podcasts
